Quarterly labs are a standard part of every TelosRX sermorelin plan. They give your provider objective information about how you are doing, rather than relying only on how you feel, and they help guide any dose adjustments your provider recommends along the way.
Labs happen roughly every three months. They are included in your plan at no extra step to arrange, and your provider uses the results alongside how you are feeling to decide whether anything about your plan should change. Any adjustment is subject to medical approval by a licensed provider.
Start your intake →Why labs are part of the plan
Self-reported feeling is a genuinely useful signal, but it is an unreliable one on its own. Sleep, stress, and unrelated life events can all shift how someone feels week to week, independent of anything related to their treatment.
Labs give your provider a data point that does not depend on mood or memory. Comparing results over time helps distinguish a real pattern from ordinary week-to-week noise in how you happen to feel on a given day.
Sermorelin's published evidence base is thinner than long-established prescription drug classes. Providers rely more heavily on individual monitoring like labs to guide decisions, rather than a large body of trial data.
What quarterly means in practice
Quarterly generally means roughly every three months, though your provider may adjust the exact cadence based on your specific plan and how your first results look. It is a guideline, not a rigid calendar requirement enforced without judgment.
Labs are included in your plan, so there is no separate step to schedule or pay for them outside your regular care. Your care team will let you know when it is time and how to complete the process.
If you miss a lab window because of travel or a busy stretch, message your care team rather than skipping it entirely. Rescheduling is straightforward, and a slightly delayed lab is far better than one that never happens.
What providers look for
Your provider is looking for patterns relevant to your specific plan and goals, not a single universal checklist that applies identically to everyone. What matters for one patient may be less relevant for another, depending on their history.
Results are interpreted alongside your reported experience, not in isolation. A provider considers both together rather than making decisions purely from a number on a lab report without context.
You do not need to interpret your own results before your provider reviews them. That is their role, and trying to self-diagnose from a raw lab report is more likely to cause unnecessary worry than clarity.
If a number on your report looks unfamiliar or concerning before you have heard from your provider, resist the urge to search for it online. General reference ranges rarely capture the context your provider has for your specific plan.
Key takeaway: Quarterly labs are included in your plan and give your provider objective data. They work alongside how you feel, not in place of it, to guide any adjustments.
How labs connect to dose adjustments
If your provider recommends a dose adjustment, labs are typically part of the reasoning behind that recommendation. It is a decision grounded in your specific data, not a general schedule that applies the same change to everyone.
Do not adjust your own dose based on how you interpret a lab result yourself. That decision belongs to your provider, who is weighing your labs against your full history and your reported experience together.
Ask your provider to walk you through their reasoning if you are curious. Most providers are glad to explain a recommendation in plain terms rather than simply stating a change without context.
Understanding the reasoning also helps you notice similar patterns in how you feel going forward. That awareness can make future check-ins more productive, since you already know what your provider is looking for.
What to do between labs
Message your care team if something feels notably different between scheduled labs. You do not need to wait for your next quarterly check-in to raise a concern that feels significant to you.
Keeping a simple, brief note of anything notable, such as sleep or energy changes, helps you describe your experience accurately at your next check-in. Memory from months earlier is not always reliable.
Staying consistent with your general routine between labs also helps your provider interpret results more clearly, since inconsistent habits can introduce noise that makes patterns harder to see in your data.
Start your sermorelin intake →
Cost and logistics
Quarterly labs are included in your sermorelin plan through TelosRX, which starts as low as $125 per month. There is no separate lab bill to budget for outside your regular plan cost.
Logistics are handled by your care team, who will let you know what is needed and how to complete the process. You are not left to figure out lab scheduling on your own without guidance.
If you have not started sermorelin yet, monitoring is worth factoring into how you think about the overall plan. Start your intake and ask your provider what your first quarterly cycle will look like once you are approved.
Most patients find that once the first lab cycle is behind them, the process becomes familiar. It settles into an unremarkable part of an ongoing plan, not something to dwell on between check-ins.
If you have questions about how labs fit into your specific plan, raise them during intake or in an early message to your care team once enrolled. Combined care, such as also using the NAD+ nasal spray, may involve its own monitoring conversation with your provider.
Why consistency matters more than any single result
A single lab result is a snapshot, not the full picture. Your provider is generally more interested in the trend across multiple quarters than in any one result taken alone.
This is one more reason not to skip scheduled labs, even if you feel your plan is going well. Consistent monitoring is what makes the trend meaningful, and a gap in that record makes future comparisons less useful.
If your results are stable and unremarkable quarter after quarter, that is not a wasted step. It is confirmation that your current plan continues to make sense, which is valuable information in its own right.
Some patients ask whether they can request labs more often than quarterly. Message your care team if you have a specific reason to want closer monitoring, and your provider can decide whether that makes sense for your situation.
Conversely, if quarterly labs feel excessive once your plan has been stable for a long time, that is also worth raising. Your provider may adjust the cadence based on how established and consistent your plan has become, though many patients simply keep the standard schedule indefinitely.
What a typical lab check-in looks like
Once your lab work is complete, your provider reviews the results alongside your history and any notes from your recent messages. This is not a separate appointment you need to book, since review happens as part of your ongoing plan.
You will hear back from your care team with a summary and any recommendations that follow from the results. If your provider suggests a change, they will explain the reasoning in terms you can follow, not just a new instruction without context.
If your results raise a question your provider wants to explore further, they may ask for additional information from you or suggest a follow-up. This is a normal part of thorough care, not a sign something has gone wrong.
Most quarterly check-ins are routine and confirm that a plan is on track. Providers do not need to see something dramatic in your results to consider the process working as intended for you.
It helps to think of each check-in as a scheduled opportunity for a fresh look at your plan, rather than a test you could pass or fail. Providers use it to confirm the plan still fits, not to judge your effort or commitment.
Over several quarters, this rhythm builds a fuller picture than any single visit could. Your provider gets to know your patterns, and you get a regular, low-effort touchpoint that keeps your plan from drifting unnoticed in either direction.
Combining labs with other TelosRX peptides
Are you considering more than one compounded peptide, such as sermorelin alongside BPC-157 or PT-141. Mention that during intake so your provider can plan monitoring accordingly.
Monitoring needs can differ depending on what you are taking together. Your provider is best positioned to decide what makes sense for your specific combination, rather than assuming one schedule automatically fits another plan.
Whatever combination you are considering, start with an honest conversation. Start your sermorelin intake and raise any related questions with your provider once you are enrolled.
Frequently Asked Questions
How often are labs required on a sermorelin plan?
Quarterly labs, roughly every three months, are standard. Your provider may adjust the exact cadence slightly based on your specific plan and results.
Do I have to pay separately for quarterly labs?
No. Quarterly labs are included as part of your sermorelin plan through TelosRX, with no separate bill to arrange outside your regular plan cost.
What happens if I miss a scheduled lab window?
Message your care team to reschedule. A delayed lab is far better than skipping it, and rescheduling is a straightforward process handled by your care team.
Can I adjust my own dose based on a lab result?
No. Dose adjustments are a decision for your provider, who weighs your labs alongside your full history and reported experience together, not a number in isolation.
Do I need to interpret my own lab results?
No. Your provider reviews and interprets results as part of your care. You can ask them to explain their reasoning in plain terms if you are curious.
Should I message my care team between scheduled labs?
Yes, if something feels notably different. You do not need to wait for your next quarterly check-in to raise a concern that feels significant to you.
TelosRX is LegitScript-certified. Sermorelin is compounded and not FDA-approved, and it is prepared by partner compounding pharmacies in the United States. This article is general information, not medical advice, and does not replace guidance from your own provider. Care is subject to medical approval by a licensed provider, and approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
For general background on growth hormone-releasing peptides, see the NIH-indexed review of GH-IGF1 axis peptides. For how compounded medication is regulated in the United States, see the FDA overview of drug compounding.
Questions about monitoring? Message the TelosRX care team or learn more on the TelosRX sermorelin page.